Aridis Pharmaceuticals, Inc.
Targets of Acinetobacter baumannii
Last updated:
Abstract:
The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.
Status:
Grant
Type:
Utility
Filling date:
7 Sep 2018
Issue date:
31 Mar 2020